Please provide your email address to receive an email when new articles are posted on . The U.S. Federal Trade Commission voted 3-2 on Feb. 19 to approve the $2 billion merger between Fresenius ...

WALTHAM, Mass. and DENVER, March 23, 2021 /PRNewswire/ -- Fresenius Medical Care North America (FMCNA) and DaVita Kidney Care today announced an expanded agreement to provide home dialysis ...

Please provide your email address to receive an email when new articles are posted on . NxStage Medical Inc. is celebrating its 10th year anniversary this summer of the Food and Drug Administration's ...

WALTHAM, Mass., Sept. 4, 2024 /PRNewswire/ -- Fresenius Medical Care (FME), a global leader in kidney care, has achieved a growth milestone of more than 14,000 U.S.-based patients using the Company's ...

The pending acquisition by Fresenius put NxStage's second-quarter financial report in a much different context. Coming into Monday's second-quarter financial report, NxStage investors had no inkling ...

Here's the good news the dialysis specialist needed. Over the past couple of weeks, two SEC filings from NxStage have provided more color on where the dialysis specialist is headed. With the ...

The Wall Street Journal received more than 600 applications from nearly two-dozen countries for the awards event. The NxStage System One is the smallest, commercially-available hemodialysis system. It ...

In a clinical policy bulletin update on Friday, Aetna (AET) said it considers the NxStage System (NXTM) portable hemodialysis machine an "equally acceptable alternative to standard hemodialysis ...

One of the leading manufacturers of innovative dialysis products – Nxstage Medical, Inc. (NXTM) – recently secured the U.S. Food and Drug Administration (FDA) approval for its home nocturnal ...